Safety aspects and cholesterol-lowering efficacy of chitosan tablets
- PMID: 18460478
- DOI: 10.1080/07315724.2008.10719671
Safety aspects and cholesterol-lowering efficacy of chitosan tablets
Abstract
Objective: The purpose of this study was to determine the effect of two different doses of chitosan on serum fat-soluble vitamin concentrations, cholesterol concentrations, and other safety parameters.
Methods: A total of 65 men and women consumed 0, 4.5, 6.75 g per day of chitosan or 6.75 g per day glucomannan for eight weeks in a parallel, placebo-controlled, single-blind study. Altogether, 56 participants completed the study.
Results: No differences were detected among the treatments in serum vitamins (vitamin A, vitamin E, 25-hydroxyvitamin D), carotenes (alpha- and beta-carotene), clinical chemistry or hematology measurements. The changes in the total and LDL-cholesterol concentrations among the study groups were not statistically significant.
Conclusion: In the present study, the consumption of chitosan tablets was found to be safe, but there was no significant effect on cholesterol concentration.
Similar articles
-
Retinol, vitamin D, carotenes and alpha-tocopherol in serum of a moderately hypercholesterolemic population consuming sitostanol ester margarine.Atherosclerosis. 1999 Aug;145(2):279-85. doi: 10.1016/s0021-9150(99)00078-7. Atherosclerosis. 1999. PMID: 10488954 Clinical Trial.
-
The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins.Clin Nutr. 2010 Feb;29(1):112-8. doi: 10.1016/j.clnu.2009.08.005. Epub 2009 Aug 26. Clin Nutr. 2010. PMID: 19709787 Clinical Trial.
-
Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial.Mayo Clin Proc. 1999 Dec;74(12):1198-206. doi: 10.4065/74.12.1198. Mayo Clin Proc. 1999. PMID: 10593347 Clinical Trial.
-
Plasma fat-soluble vitamin and carotenoid concentrations after plant sterol and plant stanol consumption: a meta-analysis of randomized controlled trials.Eur J Nutr. 2017 Apr;56(3):909-923. doi: 10.1007/s00394-016-1289-7. Epub 2016 Sep 3. Eur J Nutr. 2017. PMID: 27591863 Free PMC article. Review.
-
Cholesterol-lowering properties and safety of chitosan.Arzneimittelforschung. 2002;52(1):1-7. doi: 10.1055/s-0031-1299848. Arzneimittelforschung. 2002. PMID: 11838268 Review.
Cited by
-
Formulation and antibacterial properties of lollipops containing of chitosan- zinc oxide nano particles on planktonic and biofilm forms of Streptococcus mutans and Lactobacillus acidophilus.BMC Oral Health. 2023 Dec 1;23(1):957. doi: 10.1186/s12903-023-03604-9. BMC Oral Health. 2023. PMID: 38041064 Free PMC article.
-
Dietary fibre for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2016 Jan 7;2016(1):CD011472. doi: 10.1002/14651858.CD011472.pub2. Cochrane Database Syst Rev. 2016. PMID: 26758499 Free PMC article.
-
Recent Advances in Chitosan-Based Carriers for Gene Delivery.Mar Drugs. 2019 Jun 25;17(6):381. doi: 10.3390/md17060381. Mar Drugs. 2019. PMID: 31242678 Free PMC article. Review.
-
TPGS-modified Chitosan Nanoparticles of EGFR Inhibitor: Physicochemical and In vitro Evaluation against HepG2 Cell Lines.Curr Drug Deliv. 2025;22(4):465-478. doi: 10.2174/0115672018268315231206045504. Curr Drug Deliv. 2025. PMID: 38204256
-
Tailoring Drug Release Properties by Gradual Changes in the Particle Engineering of Polysaccharide Chitosan Based Powders.Polymers (Basel). 2017 Jun 29;9(7):253. doi: 10.3390/polym9070253. Polymers (Basel). 2017. PMID: 30970933 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical